While initial glycemic control can be achieved using oral antidiabetic drugs (OADs), it might be challenging to attain the target levels in individuals with T2DM as the disease progresses, necessitating a combination of medications and the initiation of insulin therapy [2]. The gene discussed is INS; the disease is type 2 diabetes mellitus.